Results 101 to 110 of about 22,177 (184)

Circulating miR-18b-3p is a novel biomarker predicting chemo-radiotherapy induced oral mucositis in head and neck cancer. [PDF]

Signal Transduct Target Ther
Pulito C, Brandi R, Sestito R, Orlandi G, Sanguineti G, Blandino G, Strano S.   +6 more
europepmc   +1 more source

Immune-Mediated Thrombocytopenia Induced by Niraparib: A Clinically Relevant Case. [PDF]

Cureus
Roxo F, Duarte D, Abreu MH.
europepmc   +1 more source

Expression of MIR155HG, LOC283856, KIAA0125, and LOC100190986 as potential prognostic and predictive biomarkers for breast cancer. [PDF]

Braz J Med Biol Res
Pavanelli AC, Mangone FRR, Jesus GP, Nagai MA.   +3 more
europepmc   +1 more source

Chemoimmunotherapy Combinations in Elderly Patients with Metastatic Non-Small Cell Lung Cancer and PD-L1 Expression < 50%: Results from an Italian Real-World Study. [PDF]

J Clin Med
Veccia A, D'Argento E, Morgillo F, Pizzutilo EG, Vitiello F, Pavan A, Lombardo F, Russano M, Morabito A, Gariazzo E, Genova C, Chiari R, Cristofano A, Delconte A, Vattemi E, Dessi A, Galanti D, Busato S, Palazzolo G, Savastano C, Azzarello G, Verderame F, Mazzi C, Bencardino D, Dipasquale M, Scala A, Della Corte CM, Piscazzi D, Gilli M, Bria E, Caffo O, Gori S, Inno A.   +32 more
europepmc   +1 more source

Editorial Expression of Concern: Two novel human anti-ErbB2 immunoagents are active on trastuzumab-resistant tumours. [PDF]

Br J Cancer
Gelardi T, Damiano V, Rosa R, Bianco R, Cozzolino R, Tortora G, Laccetti P, D'Alessio G, De Lorenzo C.   +8 more
europepmc   +1 more source

Pathogenic MAX Variant in Bilateral Adrenal Paragangliomas: The Dilemma of Cortical-Sparing Surgery. [PDF]

Cureus
Carmona Alexandrino H, Martins Fernandes A, Godinho R, Castelo Branco N, Martins R.   +4 more
europepmc   +1 more source

Protocol for a non-inferiority randomized controlled trial of spontaneous breathing trial in children with and without pressure support. [PDF]

Crit Care Sci
Colleti Junior J, Araujo OR, Weber KT, Santos GMVD, Silva DCBD, Volpon LC, Carlotti APCP.   +6 more
europepmc   +1 more source

Meet-URO Score Validation in Real-world Patients with Metastatic Renal Cell Carcinoma Receiving First-line Pembrolizumab Plus axitinib: A Subanalysis of the Prospective ProPAXI Study. [PDF]

J Kidney Cancer VHL
Airò G, Guida A, Gili A, Signori A, Rebuzzi SE, Maruzzo M, Lai E, Pierantoni F, Bimbatti D, Basso U, Damassi A, Calabrò F, Cerbone L, Caserta C, Sirgiovanni G, Serafin D, Caffo O, Scagliarini S, Bracarda S, Buti S.   +19 more
europepmc   +1 more source

A topical nociceutical formulation ameliorates chemotherapy-induced peripheral neuropathy: a pilot randomized clinical study. [PDF]

Clin Transl Oncol
Servitja S, Castro-Henriques M, Álvarez-Busto I, Díez-Franco C, Medina-Castillo A, Algarra-García MA, López-Miranda E, Lario-Martínez M, Luengo-Alcázar MI, Borregón M, Davó A, Gasull-Delgado A, Roque-García S, Gonzaga-López A, Poveda-Ferriols JM, Pascal S, Mitroi-Marinescu AM, García-Escolano M, Fernández-Carvajal A, Ferrándiz-Huertas C, Ferrer-Montiel A.   +20 more
europepmc   +1 more source

[Teratoid Wilms tumor in an adult: A case report]. [PDF]

Rev Med Inst Mex Seguro Soc
Hernández-Marchena YN, González-Medina WE, Bolado-García PB, Surur-Zaibak EE, Balderas YO, Hernández-Valadez OF, Marrufo-Solís V, Luna HDL, García-Saury K, Méndez-Gutierrez J.   +9 more
europepmc   +1 more source